Royal Bank Of Canada Fate Therapeutics Inc Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 12,171 shares of FATE stock, worth $20,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,171
Previous 9,832 23.79%
Holding current value
$20,203
Previous $32,000 31.25%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.12 - $5.57 $7,297 - $13,028
2,339 Added 23.79%
12,171 $42,000
Q2 2024

Aug 14, 2024
BUY
$3.26 - $7.08 $25,538 - $55,464
7,834 Added 392.09%
9,832 $32,000
Q1 2024

Nov 05, 2024
SELL
$3.54 - $8.35 $27,732 - $65,413
-7,834 Reduced 79.68%
1,998 $14,000
Q1 2024

May 15, 2024
SELL
$3.54 - $8.35 $89,172 - $210,336
-25,190 Reduced 92.65%
1,998 $14,000
Q4 2023

Feb 14, 2024
BUY
$1.65 - $3.94 $21,172 - $50,558
12,832 Added 89.38%
27,188 $101,000
Q3 2023

Nov 14, 2023
BUY
$2.02 - $5.04 $7,803 - $19,469
3,863 Added 36.82%
14,356 $30,000
Q2 2023

Aug 14, 2023
BUY
$4.76 - $6.59 $16,098 - $22,287
3,382 Added 47.56%
10,493 $49,000
Q1 2023

May 15, 2023
SELL
$4.24 - $11.12 $67,929 - $178,153
-16,021 Reduced 69.26%
7,111 $40,000
Q4 2022

Feb 14, 2023
BUY
$9.86 - $23.83 $182,972 - $442,213
18,557 Added 405.62%
23,132 $233,000
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $11,698 - $20,049
556 Added 13.83%
4,575 $103,000
Q2 2022

Aug 15, 2022
SELL
$17.78 - $42.39 $127,251 - $303,385
-7,157 Reduced 64.04%
4,019 $100,000
Q1 2022

May 16, 2022
SELL
$29.67 - $60.28 $467,955 - $950,736
-15,772 Reduced 58.53%
11,176 $433,000
Q4 2021

Feb 14, 2022
BUY
$47.84 - $64.34 $778,739 - $1.05 Million
16,278 Added 152.56%
26,948 $1.58 Million
Q3 2021

Nov 15, 2021
SELL
$59.27 - $95.73 $8.29 Million - $13.4 Million
-139,818 Reduced 92.91%
10,670 $633,000
Q2 2021

Aug 16, 2021
BUY
$67.25 - $92.52 $10.1 Million - $13.9 Million
150,488 New
150,488 $13.1 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email